Filing Flows › Yarrow Bioscience (YARW) › Q1 2026 › vs Q1 2025
Yarrow Bioscience (YARW) Q1 2026 vs Q1 2025 (year over year)
Yarrow Bioscience's revenue fell $116K (-57%) from $202K in Q1 2025 to $86K in Q1 2026.
Yarrow Bioscience, Q1 2026: revenue $86K (-57% year over year), net loss $3.6M, operating cash flow −$4.1M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $86K | $202K | −$116K | -57% |
| Other income, net | $231K | $594K | −$363K | -61% |
| Net loss | $3.6M | $8.6M | −$5.0M | -58% |
| Costs & expenses | $3.9M | $9.4M | −$5.5M | -59% |
| Operating costs | $3.9M | $9.4M | −$5.5M | -58% |
| Research & development | $817K | $6.1M | −$5.3M | -87% |
| General & admin | $3.1M | $3.3M | −$190K | -6% |
| Operating cash sources | $4.6M | $12.2M | −$7.7M | -63% |
| Depreciation | $6K | $6K | $0 | 0% |
| Share-based compensation | $474K | $763K | −$289K | -38% |
| Cash used in operations | $4.1M | $11.5M | −$7.4M | -64% |
| Net loss absorbed | $3.6M | $8.6M | −$5.0M | -58% |
| Working capital & other | $976K | $3.6M | −$2.6M | -73% |
Questions
How much did Yarrow Bioscience's revenue grow year over year in Q1 2026?
Yarrow Bioscience's revenue fell $116K (-57%) from $202K in Q1 2025 to $86K in Q1 2026.